Just one third of patients with depression respond to their initial medication trial while a similar number have no adequate clinical response after being treated with several different medications, according to a new STAR*D study conducted by researchers at National Institute of Mental Health. A new study published in iBiological Psychiatry/i now shares progress in identifying genomic predictors of antidepressant response. Many previous studies ...Sunday, 31 March 2013
Around Two Thirds of Patients Fail to Respond to Initial Antidepressant Medication
Just one third of patients with depression respond to their initial medication trial while a similar number have no adequate clinical response after being treated with several different medications, according to a new STAR*D study conducted by researchers at National Institute of Mental Health. A new study published in iBiological Psychiatry/i now shares progress in identifying genomic predictors of antidepressant response. Many previous studies ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment